
MIRA Pharmaceuticals, Inc.
MIRAHealthcare|Drug Manufacturers - General|US
$0.57
+0.03 (+5.61%)
DCF Value
$0.26
Tangible Book / Share
$0.19
Cash / Share
$0.19
Next Earnings Report
Dec 2, 2026
EPS est. -$0.03
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Dec 5, 2025 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
Oct 29, 2026 · GlobeNewsWire
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
Oct 22, 2026 · GlobeNewsWire
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
Sep 17, 2026 · GlobeNewsWire
Miravalles Gold Corp. Files NI 43-101 Technical Report for Fairfield Gold Project, Nayarit, Mexico
Sep 3, 2026 · Newsfile Corp
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
Sep 1, 2026 · GlobeNewsWire
SEC Filings (71)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 28, 2026 | 8-K | Material event | DocumentIndex |
| Oct 22, 2026 | 8-K | Material event | DocumentIndex |
| Sep 17, 2026 | 8-K | Material event | DocumentIndex |
| Sep 16, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 6, 2026 | 8-K | Material event | DocumentIndex |
| Jun 25, 2026 | 8-K | Material event | DocumentIndex |
| Jun 17, 2026 | 8-K | Material event | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| Jun 4, 2026 | 8-K | Material event | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 23, 2026 | 8-K | Material event | DocumentIndex |
| Mar 3, 2026 | 8-K | Material event | DocumentIndex |
| Feb 2, 2026 | 8-K | Material event | DocumentIndex |
| Dec 22, 2025 | 8-K | Material event | DocumentIndex |
| Dec 5, 2025 | 8-K | Material event | DocumentIndex |
| Dec 5, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 23, 2025 | 8-K | Material event | DocumentIndex |
| Oct 16, 2025 | 8-K | Material event | DocumentIndex |
| Oct 15, 2025 | 8-K | Material event | DocumentIndex |
| Sep 30, 2025 | 8-K | Material event | DocumentIndex |
| Sep 22, 2025 | 8-K | Material event | DocumentIndex |
| Sep 15, 2025 | 8-K | Material event | DocumentIndex |
| Sep 11, 2025 | 8-K | Material event | DocumentIndex |
| Aug 19, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2025 | 8-K | Material event | DocumentIndex |
| Aug 8, 2025 | DEFM14A | Proxy / shareholder vote | DocumentIndex |
| Aug 8, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 29, 2025 | PRER14A | DocumentIndex |